论文部分内容阅读
目的研究甲状腺癌伴有桥本甲状腺炎的临床病理情况。方法选取我院2012年9月-2013年9月间23例桥本甲状腺炎伴有甲状腺癌的患者作为观察组,并与对照组(同期诊治的23例桥本甲状腺炎)患者予以对比,分析两组临床症状、病理特点、检测RET的阳性率等。结果对照组临床表现存在多样化特点,大多数呈结节状。观察组呈乳头状癌,检测RET结果阳性率显著性高于对照组(P<0.05)。结论甲状腺癌同桥本甲状腺炎临床具有一定程度的相同病理基础,桥本甲状腺炎极大可能是引起患者并存甲状腺癌的重要因素,给予桥本甲状腺炎患者积极治疗,能有效防止患者并存甲状腺癌,临床应予重视。
Objective To investigate the clinicopathological features of thyroid cancer accompanied by Hashimoto’s thyroiditis. Methods Twenty-three patients with Hashimoto’s thyroiditis and thyroid cancer in our hospital from September 2012 to September 2013 were selected as the observation group and compared with the control group (23 Hashimoto’s thyroiditis patients treated at the same period) Two groups of clinical symptoms, pathological features, detection of RET positive rate. Results The clinical manifestations of the control group showed diversified features, most of them were nodular. The observation group showed papillary carcinoma. The positive rate of RET in the test group was significantly higher than that in the control group (P <0.05). Conclusions Thyroid cancer with Hashimoto’s thyroiditis has a certain degree of clinical pathology, and Hashimoto’s thyroiditis may be an important factor in causing thyroid cancer. Hashimoto’s thyroiditis is an active treatment for patients with thyroid cancer , Clinical should pay attention.